Parkside Financial Bank & Trust’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.77K Sell
115
-10
-8% -$766 ﹤0.01% 1705
2026
Q1
$10.1K Hold
125
– – ﹤0.01% 1580
2025
Q4
$9.55K Buy
125
+10
+9% +$767 ﹤0.01% 1588
2025
Q3
$9.14K Buy
115
+95
+475% +$7.11K ﹤0.01% 1542
2025
Q2
$1.4K Hold
20
– – ﹤0.01% 2122
2025
Q1
$1.48K Buy
+20
New +$1.41K ﹤0.01% 1975
2020
Q3
– Sell
-101
Closed -$6K – 1611
2020
Q2
$6K Hold
101
– – ﹤0.01% 901
2020
Q1
$5K Hold
101
– – ﹤0.01% 888
2019
Q4
$8K Hold
101
– – ﹤0.01% 844
2019
Q3
$8K Hold
101
– – ﹤0.01% 829
2019
Q2
$8K Hold
101
– – ﹤0.01% 852
2019
Q1
$8K Hold
101
– – ﹤0.01% 841
2018
Q4
$8K Buy
+101
New +$7.61K ﹤0.01% 804

Other funds holding NHI

Parkside Financial Bank & Trust's NHI Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its National Health Investors (NHI) stake by 8% in Q2 2026, selling an estimated $766 and leaving 115 shares worth $8.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Parkside Financial Bank & Trust first reported a position in NHI in Q4 2018 and has held it in 13 quarters since. The position peaked at $10.1K in Q1 2026. 304 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Parkside Financial Bank & Trust held 115 shares of National Health Investors worth $8.77K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 10 National Health Investors shares in Q2 2026, an estimated $766.
  • National Health Investors made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1705 holding.
  • Parkside Financial Bank & Trust first reported a position in National Health Investors in Q4 2018 and has held it in 13 quarters since.
  • Parkside Financial Bank & Trust's National Health Investors position peaked at $10.1K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.